MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities,
short-term
$76,602K
Cash and cash
equivalents
$51,796K
Prepaid expenses and
other current assets
$4,696K
Total current assets
$133,094K
Other assets,
long-term
$304K
Restricted cash
$231K
Total assets
$133,629K
Total liabilities and
stockholders equity
$133,629K
Total stockholders
equity
$87,476K
Total liabilities
$46,153K
Accumulated deficit
-$467,199K
Additional paid-in capital
$554,647K
Total current
liabilities
$29,229K
Debt, long-term
$16,924K
Accumulated other
comprehensive income
$21K
Common stock, 0.0001
par value...
$7K
Debt, short-term
$14,123K
Accrued clinical trial
expenses
$8,183K
Accrued expenses and
other current...
$5,268K
Accounts payable
$1,655K
Back
Back
Balance Sheet
Acumen Pharmaceuticals, Inc. (ABOS)
Acumen Pharmaceuticals, Inc. (ABOS)
source: myfinsight.com